Product Name :
PRDM3 (M1) Peptide Applications :
Blocking Background :
PRDM3 can be produced either as a separate transcript and as a fusion transcript with EVI1. A chromosomal aberration involving PRDM3 is found in a form of acute myeloid leukemia. The myelodysplastic syndromes (MDS, formerly known as "preleukemia") are a diverse collection of hematological conditions united by ineffective production of blood cells and varying risks of transformation to acute myelogenous leukemia. Alternative Name :
MDS1; MDS1 EVI1; MDS1-EVI1; MDS1EVI1; PRDM 3; PRDM3; Swiss-Prot :
Q13465 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide PRDM3 (M1). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS2049 PRDM3 (M1) pAb.
PRDM3 (M1) Peptide Applications :
Blocking Background :
PRDM3 can be produced either as a separate transcript and as a fusion transcript with EVI1. A chromosomal aberration involving PRDM3 is found in a form of acute myeloid leukemia. The myelodysplastic syndromes (MDS, formerly known as "preleukemia") are a diverse collection of hematological conditions united by ineffective production of blood cells and varying risks of transformation to acute myelogenous leukemia. Alternative Name :
MDS1; MDS1 EVI1; MDS1-EVI1; MDS1EVI1; PRDM 3; PRDM3; Swiss-Prot :
Q13465 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide PRDM3 (M1). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS2049 PRDM3 (M1) pAb.
Blocking peptide available as BS2049PP